Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19

Gastroenterology. 2020 Sep;159(3):1170-1172.e1. doi: 10.1053/j.gastro.2020.05.034. Epub 2020 May 16.
No abstract available

Keywords: ACE, angiotensin-converting enzyme; ACEI, angiotensin-converting enzyme inhibitors; ACEI/ARB; ARB, angiotensin receptor blockers; COVID-19; COVID-19, coronavirus disease 2019; Digestive System; GI, gastrointestinal; Liver Injury.

MeSH terms

  • Aged
  • Angiotensin Receptor Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Betacoronavirus*
  • COVID-19
  • China
  • Coronavirus Infections / complications*
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / mortality*
  • Female
  • Gastrointestinal Diseases / epidemiology*
  • Humans
  • Hypertension / drug therapy
  • Length of Stay
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / mortality*
  • Retrospective Studies
  • SARS-CoV-2
  • Survival Rate
  • Symptom Assessment

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors